Telomir Pharmaceuticals, Inc. (TELO)

Telomir Pharmaceuticals Market Cap

Telomir Pharmaceuticals has a market cap or net worth of $203.27 million as of April 26, 2024.

• Market Cap: 203.27M
• Enterprise Value: 203.37M
• 1-Year Change: n/a
• Ranking: #3621
• Category: Micro-Cap
• Stock Price: $6.87

Market Cap Chart

Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $203.27M, a decrease of -1.93%.

Market Cap History

Date	Market Cap	% Change
Apr 26, 2024	203.30M	0.99%
Apr 25, 2024	201.30M	-2.47%
Apr 24, 2024	206.40M	19.79%
Apr 23, 2024	172.30M	3.80%
Apr 22, 2024	166.00M	-29.78%
Apr 19, 2024	236.40M	0.42%
Apr 18, 2024	235.40M	-6.25%
Apr 17, 2024	251.10M	1.33%
Apr 16, 2024	247.80M	-5.35%
Apr 15, 2024	261.80M	-1.76%
Apr 12, 2024	266.50M	9.76%
Apr 11, 2024	242.80M	6.63%
Apr 10, 2024	227.70M	12.28%
Apr 9, 2024	202.80M	2.06%
Apr 8, 2024	198.70M	-5.47%
Apr 5, 2024	210.20M	-2.87%
Apr 4, 2024	216.40M	31.55%
Apr 3, 2024	164.50M	1.11%
Apr 2, 2024	162.70M	0.62%
Apr 1, 2024	161.70M	6.03%
Mar 28, 2024	152.50M	1.26%
Mar 27, 2024	150.60M	-8.51%
Mar 26, 2024	164.60M	0.18%
Mar 25, 2024	164.30M	-14.52%
Mar 22, 2024	192.20M	-4.43%

View and export this data all the way back to 2024. Sign Up Today.

Related Stocks

Company	Market Cap
Merrimack Pharmaceuticals	213.76M
Adverum Biotechnologies	211.49M
G1 Therapeutics	208.28M
Actinium Pharmaceuticals	207.54M
Lineage Cell Therapeutics	207.39M
Zura Bio	206.30M
Design Therapeutics	204.41M
Galectin Therapeutics	203.66M